TMEM16A/ANO1 suppression improves response to antibody‐mediated targeted therapy of EGFR and HER2/ERBB2Sucheta Kulkarni, Umamaheswar Duvvuri, Neal R. Godse et al.|Genes Chromosomes and Cancer|2017Cited by 46